Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03534830 · ClinicalTrials.gov registry record
A Novel Assay for Predicting Surgical Outcomes in Pelvic Organ Prolapse
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 51
- Enrollment target
NCT03534830 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 51 participants.
The verdict
NCT03534830 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The research objective of this proposal is to investigate the clinical utility and validity of eLASV as a personalized marker for women's individual risk of recurrence for pelvic organ prolapse following advanced surgical procedures. Estimated levator ani subtended volume (eLASV) is a reproducible magnetic resonance image of the female pelvis that objectively quantifies the integrity of the pelvic floor levator ani muscles. A woman's levator ani muscle anatomical shape is unique to her as a result of her own individual lifetime risk for development of pelvic floor dysfunction. The novelty of eLASV as a measurement of muscle integrity, separates it methodology from the solitary of diagnosing partial trauma or defects as previously published within the literature. eLASV measurements have the potential to identify women at increased risk for surgical failure and may be used as a prognostic tool to aid in future counseling and stratification of patients into surgical options for treatment of pelvic organ prolapse.
Interventions
- DIAGNOSTIC_TEST MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2018-02-02 |
| Est. Completion | 2021-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03534830
The ClinicalTrials.gov registry entry for NCT03534830 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT03534830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03534830 about?
NCT03534830 is a clinical study titled "A Novel Assay for Predicting Surgical Outcomes in Pelvic Organ Prolapse". The research objective of this proposal is to investigate the clinical utility and validity of eLASV as a personalized marker for women's individual risk of recurrence for pelvic organ prolapse following advanced surgical procedures. Estimated levator ani subtended volume (eLASV) is a reproducible m...
What is the current status of trial NCT03534830?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2018-02-02. Estimated completion is 2021-01-01.
What interventions are being tested in trial NCT03534830?
The interventions under investigation include: MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03534830?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.